Shares in Pluristem Therapeutics (PSTI) rose 6% in Monday’s pre-market trading after Germany’s health regulatory agency, the Paul Ehrlich Institute (PEI), approved Pluristem’s …
Just how high can Pluristem Therapeutics (PSTI) climb? The Israeli biotech has outperformed in 2020, with shares up by 94% year-to-date.
How far are we from a viable COVID-19 treatment? Worldwide, over 178,000 people have died so far, with confirmed cases numbering more than …
Micro-cap biotech? Check.
With the war against COVID-19 waging on, Wall Street focus has locked in on the names at the frontline. Battling a formidable opponent …
Analyst Swayampakula Ramakanth of H.C.
FBR Capital analyst Vernon Bernardino weighed in on Pluristem Therapeutics Inc. (NASDAQ:PSTI) following the an announcement that the company plans to initiate a Phase I trial to …
Maxim’s healthcare analyst Jason Kolbert weighed in today on two names in his coverage universe, Anavex Life Sciences Corp. (NASDAQ:AVXL) and Pluristem Therapeutics Inc.
Tesla Motors Inc (NASDAQ:TSLA) is falling over 11% in pre-market trading following news that the electric car marker will purchase SolarCity Corp (NASDAQ:SCTY) …
In a research report issued today, H.C.
